Lactobacillus
Probiotics/Drug Interactions:
Anti-inflammatory agentsAnti-inflammatory agents: Increases in serum IL-1-beta have been observed following LGG supplementation; however, no differences were seen in IL-6, TNF-alpha, MPO, IL-10, or IL-12 (33). ImmunostimulantsImmunostimulants: In human studies, supplementation with probiotics has been shown to enhance various immune system parameters in healthy subjects (29; 44; 18; 19; 49), in HIV-positive subjects (47), and during vaccination (38; 37). ImmunosuppressantsImmunosuppressants: Based on human studies, supplementation with probiotics has been shown to enhance various immune system parameters in healthy subjects (29; 44; 18; 19; 49), in HIV-positive subjects (47), and during vaccination (38; 37). VaccinesVaccines: In human studies, supplementation with probiotics has been shown to enhance various immune system parameters in healthy subjects (29; 44; 18; 19; 49), in HIV-positive subjects (47), and during vaccination (38; 37). Probiotics/Herb/Supplement Interactions:
Anti-inflammatory herbs and supplementsAnti-inflammatory herbs and supplements: Increases in serum IL-1-beta have been observed following LGG supplementation; however, no differences were seen in IL-6, TNF-alpha, MPO, IL-10, or IL-12 (33). ImmunostimulantsImmunostimulants: In human studies, supplementation with probiotics has been shown to enhance various immune system parameters in healthy subjects (29; 44; 18; 19; 49), in HIV-positive subjects (47), and during vaccination (38; 37). ImmunosuppressantsImmunosuppressants: In human studies, supplementation with probiotics has been shown to enhance various immune system parameters in healthy subjects (29; 44; 18; 19; 49), in HIV-positive subjects (47), and during vaccination (38; 37). Probiotics/Food Interactions:
Insufficient available evidence.Probiotics/Lab Interactions:
Immune panelImmune panel: In human studies, supplementation with probiotics has been shown to enhance various immune system parameters in healthy subjects (29; 44; 18; 19; 49), in HIV-positive subjects (47), and during vaccination (38; 37).